logo
welcome
CNBC

CNBC

Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand

CNBC
Summary
Nutrition label

80% Informative

Eli Lilly now expects full-year 2024 revenue of about $45 billion .

New outlook would still mark a 32% jump in revenue from the prior year .

For the fourth quarter , Eli Lilly expects $13.5 billion in revenue.

The company also expects sales of $58 billion to $61 billion in fiscal 2025 .

Eli Lilly's shares dropped about 6% in early trading Tuesday .

VR Score

88

Informative language

95

Neutral language

1

Article tone

semi-formal

Language

English

Language complexity

37

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

Source diversity

1

Affiliate links

no affiliate links